ID   ABCD3_HUMAN             Reviewed;         659 AA.
AC   P28288; D3DT46; Q15271; Q6NUN5; Q96DA3; Q9H529;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=ATP-binding cassette sub-family D member 3;
DE   AltName: Full=70 kDa peroxisomal membrane protein;
DE            Short=PMP70;
GN   Name=ABCD3; Synonyms=PMP70, PXMP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASP-17.
RC   TISSUE=Liver;
RX   PubMed=1301993; DOI=10.1038/ng0492-16;
RA   Gaertner J., Moser H., Valle D.;
RT   "Mutations in the 70K peroxisomal membrane protein gene in Zellweger
RT   syndrome.";
RL   Nat. Genet. 1:16-23(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=1536884; DOI=10.1016/0167-4781(92)90510-7;
RA   Kamijo K., Kamijo T., Ueno I., Osumi T., Hashimoto T.;
RT   "Nucleotide sequence of the human 70 kDa peroxisomal membrane protein:
RT   a member of ATP-binding cassette transporters.";
RL   Biochim. Biophys. Acta 1129:323-327(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9521874; DOI=10.1006/geno.1997.5177;
RA   Gaertner J., Jimenez-Sanchez G., Roerig P., Valle D.;
RT   "Genomic organization of the 70-kDa peroxisomal membrane protein gene
RT   (PXMP1).";
RL   Genomics 48:203-208(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SUBUNIT.
RX   PubMed=10551832; DOI=10.1074/jbc.274.46.32738;
RA   Liu L.X., Janvier K., Berteaux-Lecellier V., Cartier N., Benarous R.,
RA   Aubourg P.;
RT   "Homo- and heterodimerization of peroxisomal ATP-binding cassette
RT   half-transporters.";
RL   J. Biol. Chem. 274:32738-32743(1999).
RN   [9]
RP   INTERACTION WITH PEX19.
RC   TISSUE=Brain;
RX   PubMed=10777694; DOI=10.1006/bbrc.2000.2572;
RA   Gloeckner C.J., Mayerhofer P.U., Landgraf P., Muntau A.C.,
RA   Holzinger A., Gerber J.-K., Kammerer S., Adamski J., Roscher A.A.;
RT   "Human adrenoleukodystrophy protein and related peroxisomal ABC
RT   transporters interact with the peroxisomal assembly protein PEX19p.";
RL   Biochem. Biophys. Res. Commun. 271:144-150(2000).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PEX19.
RX   PubMed=10704444; DOI=10.1083/jcb.148.5.931;
RA   Sacksteder K.A., Jones J.M., South S.T., Li X., Liu Y., Gould S.J.;
RT   "PEX19 binds multiple peroxisomal membrane proteins, is predominantly
RT   cytoplasmic, and is required for peroxisome membrane synthesis.";
RL   J. Cell Biol. 148:931-944(2000).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF GLY-478 AND SER-572.
RX   PubMed=11248239; DOI=10.1016/S0014-5793(01)02235-9;
RA   Roerig P., Mayerhofer P., Holzinger A., Gaertner J.;
RT   "Characterization and functional analysis of the nucleotide binding
RT   fold in human peroxisomal ATP binding cassette transporters.";
RL   FEBS Lett. 492:66-72(2001).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-260 AND LYS-399, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   FUNCTION, AND INVOLVEMENT IN CBAS5.
RX   PubMed=25168382; DOI=10.1093/hmg/ddu448;
RA   Ferdinandusse S., Jimenez-Sanchez G., Koster J., Denis S.,
RA   Van Roermund C.W., Silva-Zolezzi I., Moser A.B., Visser W.F.,
RA   Gulluoglu M., Durmaz O., Demirkol M., Waterham H.R., Goekcay G.,
RA   Wanders R.J., Valle D.;
RT   "A novel bile acid biosynthesis defect due to a deficiency of
RT   peroxisomal ABCD3.";
RL   Hum. Mol. Genet. 24:361-370(2015).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Probable transporter involved in the transport of
CC       branched-chain fatty acids and C27 bile acids into the peroxisome;
CC       the latter function is a crucial step in bile acid biosynthesis
CC       (PubMed:25168382). The nucleotide-binding fold acts as an ATP-
CC       binding subunit with ATPase activity (PubMed:11248239).
CC       {ECO:0000269|PubMed:11248239, ECO:0000269|PubMed:25168382}.
CC   -!- SUBUNIT: Can form heterodimers with ABCD1/ALD and ABCD2/ALDR.
CC       Dimerization is necessary to form an active transporter. Interacts
CC       with PEX19. {ECO:0000269|PubMed:10551832,
CC       ECO:0000269|PubMed:10704444, ECO:0000269|PubMed:10777694}.
CC   -!- INTERACTION:
CC       P33897:ABCD1; NbExp=2; IntAct=EBI-80992, EBI-81045;
CC       P40855:PEX19; NbExp=4; IntAct=EBI-80992, EBI-594747;
CC   -!- SUBCELLULAR LOCATION: Peroxisome membrane
CC       {ECO:0000269|PubMed:10704444}; Multi-pass membrane protein
CC       {ECO:0000255|PROSITE-ProRule:PRU00441,
CC       ECO:0000269|PubMed:10704444}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P28288-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28288-2; Sequence=VSP_031189;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P28288-3; Sequence=VSP_031187, VSP_031188;
CC   -!- DISEASE: Congenital bile acid synthesis defect 5 (CBAS5)
CC       [MIM:616278]: An autosomal recessive disorder characterized by
CC       hepatosplenomegaly, hepatic fibrosis, progressive liver failure,
CC       and accumulation of peroxisomal C27-bile acid intermediates in
CC       plasma. {ECO:0000269|PubMed:25168382}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Mutation in ABCD3 have been found in two
CC       individuals affected by Zellweger syndrome. However, the role of
CC       ABCD3 in the causation of Zellweger syndrome remains uncertain.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCD
CC       family. Peroxisomal fatty acyl CoA transporter (TC 3.A.1.203)
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC
CC       proteins;
CC       URL="http://abcmutations.hegelab.org/proteinDetails?uniprot_id=P28288";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M81182; AAA60128.1; -; mRNA.
DR   EMBL; X58528; CAA41416.1; -; mRNA.
DR   EMBL; X83467; CAA58470.1; -; Genomic_DNA.
DR   EMBL; X83468; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83469; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83470; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83471; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83472; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83473; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83474; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83475; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83476; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83477; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83478; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83479; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83480; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83481; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83482; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83483; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83484; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83485; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83486; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83487; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83488; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; X83489; CAA58470.1; JOINED; Genomic_DNA.
DR   EMBL; BT006644; AAP35290.1; -; mRNA.
DR   EMBL; AL138758; CAC15960.2; -; Genomic_DNA.
DR   EMBL; AC093117; CAC15960.2; JOINED; Genomic_DNA.
DR   EMBL; AC118469; CAC15960.2; JOINED; Genomic_DNA.
DR   EMBL; CH471097; EAW73049.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW73050.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW73047.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW73048.1; -; Genomic_DNA.
DR   EMBL; BC009712; AAH09712.1; -; mRNA.
DR   EMBL; BC068509; AAH68509.1; -; mRNA.
DR   CCDS; CCDS44175.1; -. [P28288-3]
DR   CCDS; CCDS749.1; -. [P28288-1]
DR   PIR; S20313; S20313.
DR   RefSeq; NP_001116146.1; NM_001122674.1. [P28288-3]
DR   RefSeq; NP_002849.1; NM_002858.3. [P28288-1]
DR   UniGene; Hs.700576; -.
DR   ProteinModelPortal; P28288; -.
DR   BioGrid; 111783; 71.
DR   IntAct; P28288; 41.
DR   MINT; MINT-3010926; -.
DR   STRING; 9606.ENSP00000359233; -.
DR   TCDB; 3.A.1.203.1; the atp-binding cassette (abc) superfamily.
DR   iPTMnet; P28288; -.
DR   PhosphoSitePlus; P28288; -.
DR   SwissPalm; P28288; -.
DR   BioMuta; ABCD3; -.
DR   DMDM; 130358; -.
DR   EPD; P28288; -.
DR   MaxQB; P28288; -.
DR   PaxDb; P28288; -.
DR   PeptideAtlas; P28288; -.
DR   PRIDE; P28288; -.
DR   DNASU; 5825; -.
DR   Ensembl; ENST00000315713; ENSP00000326880; ENSG00000117528. [P28288-3]
DR   Ensembl; ENST00000370214; ENSP00000359233; ENSG00000117528. [P28288-1]
DR   GeneID; 5825; -.
DR   KEGG; hsa:5825; -.
DR   UCSC; uc001dqm.5; human. [P28288-1]
DR   CTD; 5825; -.
DR   DisGeNET; 5825; -.
DR   GeneCards; ABCD3; -.
DR   HGNC; HGNC:67; ABCD3.
DR   HPA; CAB032516; -.
DR   HPA; CAB075749; -.
DR   HPA; HPA032026; -.
DR   HPA; HPA032027; -.
DR   MalaCards; ABCD3; -.
DR   MIM; 170995; gene.
DR   MIM; 616278; phenotype.
DR   neXtProt; NX_P28288; -.
DR   OpenTargets; ENSG00000117528; -.
DR   PharmGKB; PA24402; -.
DR   eggNOG; KOG0064; Eukaryota.
DR   eggNOG; COG4178; LUCA.
DR   GeneTree; ENSGT00390000003950; -.
DR   HOGENOM; HOG000206081; -.
DR   HOVERGEN; HBG050438; -.
DR   InParanoid; P28288; -.
DR   KO; K05677; -.
DR   OMA; SMMAYLI; -.
DR   OrthoDB; EOG091G04M1; -.
DR   PhylomeDB; P28288; -.
DR   TreeFam; TF105205; -.
DR   Reactome; R-HSA-1369062; ABC transporters in lipid homeostasis.
DR   ChiTaRS; ABCD3; human.
DR   GeneWiki; ABCD3; -.
DR   GenomeRNAi; 5825; -.
DR   PRO; PR:P28288; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117528; -.
DR   CleanEx; HS_ABCD3; -.
DR   Genevisible; P28288; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005782; C:peroxisomal matrix; IDA:UniProtKB.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro.
DR   GO; GO:0005324; F:long-chain fatty acid transporter activity; TAS:Reactome.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0043621; F:protein self-association; IEA:Ensembl.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IGI:UniProtKB.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0015910; P:peroxisomal long-chain fatty acid import; IEA:InterPro.
DR   GO; GO:0007031; P:peroxisome organization; IDA:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0042760; P:very long-chain fatty acid catabolic process; IGI:UniProtKB.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR031241; ABCD3.
DR   InterPro; IPR005283; FA_transporter.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11384:SF43; PTHR11384:SF43; 1.
DR   Pfam; PF06472; ABC_membrane_2; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF90123; SSF90123; 1.
DR   TIGRFAMs; TIGR00954; 3a01203; 1.
DR   PROSITE; PS50929; ABC_TM1F; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Glycoprotein; Membrane; Nucleotide-binding; Peroxisome;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P16970}.
FT   CHAIN         2    659       ATP-binding cassette sub-family D member
FT                                3.
FT                                /FTId=PRO_0000093309.
FT   TRANSMEM     84    104       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TRANSMEM    126    146       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TRANSMEM    224    244       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TRANSMEM    313    333       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   DOMAIN       85    372       ABC transmembrane type-1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN      440    659       ABC transporter. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND     473    480       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   REGION        2    199       Interaction with PEX19.
FT   REGION        2    124       Targeting to peroxisomes.
FT   MOD_RES      61     61       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P55096}.
FT   MOD_RES     260    260       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     399    399       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     533    533       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P55096}.
FT   MOD_RES     659    659       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P55096}.
FT   CARBOHYD     12     12       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    106    106       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    206    206       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     229    236       GPASMMAY -> VLGKILWH (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_031187.
FT   VAR_SEQ     237    659       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_031188.
FT   VAR_SEQ     277    386       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_031189.
FT   VARIANT      17     17       G -> D (in a patient with Zellweger
FT                                syndrome; dbSNP:rs121917999).
FT                                {ECO:0000269|PubMed:1301993}.
FT                                /FTId=VAR_000091.
FT   MUTAGEN     478    478       G->R: Decreased ATP-binding affinity.
FT                                {ECO:0000269|PubMed:11248239}.
FT   MUTAGEN     572    572       S->I: Decreased ATPase activity.
FT                                {ECO:0000269|PubMed:11248239}.
FT   CONFLICT    175    175       M -> K (in Ref. 2; CAA41416).
FT                                {ECO:0000305}.
FT   CONFLICT    191    192       QD -> LV (in Ref. 3; CAA58470).
FT                                {ECO:0000305}.
FT   CONFLICT    336    336       P -> L (in Ref. 3; CAA58470).
FT                                {ECO:0000305}.
FT   CONFLICT    503    503       G -> R (in Ref. 2; CAA41416).
FT                                {ECO:0000305}.
FT   CONFLICT    542    542       L -> Q (in Ref. 2; CAA41416).
FT                                {ECO:0000305}.
FT   CONFLICT    616    634       VGITLFTVSHRKSLWKHHE -> GWHHSLHLCLIGNLFGNI
FT                                MR (in Ref. 3; CAA58470). {ECO:0000305}.
SQ   SEQUENCE   659 AA;  75476 MW;  2CA976FEB6EB6217 CRC64;
     MAAFSKYLTA RNSSLAGAAF LLLCLLHKRR RALGLHGKKS GKPPLQNNEK EGKKERAVVD
     KVFFSRLIQI LKIMVPRTFC KETGYLVLIA VMLVSRTYCD VWMIQNGTLI ESGIIGRSRK
     DFKRYLLNFI AAMPLISLVN NFLKYGLNEL KLCFRVRLTK YLYEEYLQAF TYYKMGNLDN
     RIANPDQLLT QDVEKFCNSV VDLYSNLSKP FLDIVLYIFK LTSAIGAQGP ASMMAYLVVS
     GLFLTRLRRP IGKMTITEQK YEGEYRYVNS RLITNSEEIA FYNGNKREKQ TVHSVFRKLV
     EHLHNFILFR FSMGFIDSII AKYLATVVGY LVVSRPFLDL SHPRHLKSTH SELLEDYYQS
     GRMLLRMSQA LGRIVLAGRE MTRLAGFTAR ITELMQVLKD LNHGKYERTM VSQQEKGIEG
     VQVIPLIPGA GEIIIADNII KFDHVPLATP NGDVLIRDLN FEVRSGANVL ICGPNGCGKS
     SLFRVLGELW PLFGGRLTKP ERGKLFYVPQ RPYMTLGTLR DQVIYPDGRE DQKRKGISDL
     VLKEYLDNVQ LGHILEREGG WDSVQDWMDV LSGGEKQRMA MARLFYHKPQ FAILDECTSA
     VSVDVEGYIY SHCRKVGITL FTVSHRKSLW KHHEYYLHMD GRGNYEFKQI TEDTVEFGS
//
